Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Inogen Inc (INGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,400,696
  • Shares Outstanding, K 21,350
  • Annual Sales, $ 249,440 K
  • Annual Income, $ 21,000 K
  • 36-Month Beta 1.22
  • Price/Sales 21.80
  • Price/Cash Flow 130.03
  • Price/Book 20.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.52
  • Number of Estimates 6
  • High Estimate 0.58
  • Low Estimate 0.48
  • Prior Year 0.33
  • Growth Rate Est. (year over year) +57.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
246.32 +2.70%
on 08/27/18
287.79 -12.10%
on 09/13/18
+6.92 (+2.81%)
since 08/24/18
3-Month
177.31 +42.67%
on 06/28/18
287.79 -12.10%
on 09/13/18
+66.90 (+35.96%)
since 06/22/18
52-Week
91.80 +175.56%
on 10/05/17
287.79 -12.10%
on 09/13/18
+151.21 (+148.61%)
since 09/22/17

Most Recent Stories

More News
Should Invesco DWA SmallCap Momentum ETF (DWAS) Be on Your Investing Radar?

Style Box ETF report for DWAS

ARWR : 18.70 (+5.23%)
DWAS : 57.70 (+0.23%)
CDNA : 26.58 (+2.43%)
INGN : 252.96 (-0.68%)
Inogen (INGN) Up 14.7% Since Last Earnings Report: Can It Continue?

Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

INGN : 252.96 (-0.68%)
Inogen (INGN) Soars to 52-Week High, Time to Cash Out?

Inogen (INGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

INGN : 252.96 (-0.68%)
Here's Why You Should Buy Inogen (INGN) Stock Right Now

Inogen (INGN) gains from strong Q2 results and bright global prospects.

ITGR : 83.40 (-0.48%)
MASI : 123.82 (+1.08%)
ISRG : 569.27 (+2.25%)
INGN : 252.96 (-0.68%)
Can Inogen (INGN) Stock Continue to Grow Earnings?

Inogen (INGN) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

INGN : 252.96 (-0.68%)
Inogen Announces Management Changes

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that after nearly 15 years...

CPHD : 52.95 (unch)
INGN : 252.96 (-0.68%)
Medtronic (MDT) Grows on CRHF Arm, Margin Pressure Ails

Solid demand for Medtronic's (MDT) quadripolar cardiac resynchronization therapy-pacemakers (CRT-P) along with growth in Mechanical Circulatory Support drives Heart Failure division revenues.

ITGR : 83.40 (-0.48%)
PDCO : 25.10 (-2.22%)
MDT : 98.86 (+1.03%)
INGN : 252.96 (-0.68%)
Here's Why You Should Hold AmerisourceBergen (ABC) Stock Now (Revised)

Strong performance in the World Courier Business is likely to provide AmerisourceBergen (ABC) a competitive edge in the MedTech space.

ABC : 89.57 (-0.62%)
ITGR : 83.40 (-0.48%)
PDCO : 25.10 (-2.22%)
INGN : 252.96 (-0.68%)
Inogen Announces Participation in 16th Annual Morgan Stanley Global Healthcare Conference

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management...

MS : 48.56 (-1.72%)
INGN : 252.96 (-0.68%)
Align Technology International Growth Solid, Rivalry Rife

Align Technology's (ALGN) Invisalign Technology prospects and growth in North America and outside hold great potential for the stock, particularly in the Asia-Pacific and EMEA regions.

ITGR : 83.40 (-0.48%)
PDCO : 25.10 (-2.22%)
ALGN : 388.96 (+2.13%)
INGN : 252.96 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade INGN with:

Business Summary

Inogen, Inc. is a medical technology company. It offers oxygen concentrator, cart, carry bags, backpacks, external battery chargers and universal power supply for obstructive pulmonary disease patients. The Company's products include Inogen One G3 and Inogen One G2. It sells its products in the United...

See More

Key Turning Points

2nd Resistance Point 261.95
1st Resistance Point 257.46
Last Price 252.96
1st Support Level 248.25
2nd Support Level 243.53

See More

52-Week High 287.79
Last Price 252.96
Fibonacci 61.8% 212.92
Fibonacci 50% 189.80
Fibonacci 38.2% 166.67
52-Week Low 91.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar